Physician profile
Milo Sanda
NPI 1245779636
$5,949.67
in general payments reported to CMS, 2019-2025
14 companies · $1,097 in 2025
The $1,097 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2021: $218 · 2022: $3,064 · 2023: $1,095 · 2024: $361 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,989 · Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,988.69 |
| Food and Beverage | $563.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,676.27 | 2023-2025 | Rise, Creo Threaded, Excelsius Gps |
| Medtronic, INC. | $1,656.33 | 2022 | |
| Stryker Corporation | $1,147.49 | 2022-2024 | Spinejack, Accolade |
| Mid-Atlantic Surgical Systems, LLC | $339.96 | 2025 | |
| Arthrex, INC. | $204.95 | 2025 | |
| Kuros Biosciences USA, INC | $200.32 | 2022 | |
| Boston Scientific Corporation | $170.16 | 2024-2025 | Intracept |
| Si-Bone, INC. | $166.95 | 2021-2022 | |
| Smith+Nephew, INC. | $124.17 | 2022 | |
| Cdc Medical LLC | $96.97 | 2019 | |
| Integra Lifesciences Corporation | $69.73 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $52.46 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $25.58 | 2023 | Iovera, Exparel |
| Davol INC. | $18.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milo Sanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.